BNT162b2 vaccination induces moderate immunity against Omicron variant in children - News-Medical.Net

7/26/2022 12:00:00 AM2 years 9 months ago

Researchers evaluated the effectiveness of the BNT162b2 vaccine against the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) Omicron in five to 11-year-old children.

In a recent study published in The New England Journal of Medicine, researchers evaluated the effectiveness of the BNT162b2 vaccine against the new severe acute respiratory syndrome coronavirus 2 (SA… [+5827 chars]

full article...